ProSomnus
medical affairs active studies study objective design status expected next steps other studies | ProSomnus
Company
Deck Type
Sector
Industry
Deck date
May 2022
Slide
20 of 38
Related slides by other companies
BenevolentAI
Investor Presentation
October 2022
ben phase progressing phase double blind placebo controlled in patient two part clinical study day day day day active recruiting sites in the in a further sites under approval recruitment completion anticipated our intention is to to partner this asset with a pharmaceutical company that has a focus in dermatology for continued clinical development and if approved our intention is to out development and of ben following completion of this trial with key big and dermatology specialists as potential part | BenevolentAI
Alkermes
Investor Day
March 2021
preclinical efforts inform the clinical development strategy preclinical research clinical research molecular design confirmed selectivity demonstrated efficacy first in human studies signal seeking studies receptor selectivity maintained potency cell cell expansion minimal expansion of combination with anti mouse determined recommended phase dose from safety and data responses in multiple tumor types and in combination with anti pivotal studies combination with demonstrate efficacy with complementary mechanisms potential expansion of clinical program growth factor pathway inhibitors chemotherapy radiation other agents new combinations new indications new collaborations a sab at oft | Alkermes
Thorne HealthTech
IPO
September 2021
clinical research studies support brand and partnerships | Thorne HealthTech
SmileDirectClub
Investor Presentation
May 2021
journal of dental research and reports clinical study confirms effectiveness of clear aligner care | SmileDirectClub
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io